Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERMES: Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
NCT07146074Recruiting
- Sponsor
- Center for Oncological Research
- Start
- Feb 2025
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in bone metastases (2 arms), sponsored by Center for Oncological Research. Primary endpoint: Time to a symptomatic skeletal related event (SSE) in any bone metastasis or death due to any cause up to 24 months. Started Feb 2025; status: recruiting.
02
Conditions
bone metastases
Beyond the preview
Go deeper on NCT07146074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146074.